Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2021

Mar 3, 2021

35146_dirs_2021-03-03_40d76c71-6f8c-4552-9c10-a6f615dc9573.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2021-03-01

Reporting Person: Moccia Robert Joseph (Director, President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Employee Stock Option $1.73 A 1632590 Acquired 2031-03-01 Common Stock (1632590) Direct

Footnotes

F1: Stock options to purchase 544,198 shares of common stock vest on the first anniversary of the grant date, and stock options to purchase 136,049 shares of common stock vest on each of June 1, 2022, September 1, 2022, December 1, 2022, March 1, 2023, June 1, 2023, September 1, 2023, December 1, 2023 and March 1, 2024.